GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » Earnings per Share (Diluted)

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Earnings per Share (Diluted) : $-0.72 (TTM As of Dec. 2007)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition Earnings per Share (Diluted)?

Oracle Healthcare Acquisition's Earnings per Share (Diluted) for the three months ended in Dec. 2007 was $-0.38. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.72.

Oracle Healthcare Acquisition's EPS (Basic) for the three months ended in Dec. 2007 was $-0.38. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.69.

Oracle Healthcare Acquisition's EPS without NRI for the three months ended in Dec. 2007 was $-0.13. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2007 was $-0.95.


Oracle Healthcare Acquisition Earnings per Share (Diluted) Historical Data

The historical data trend for Oracle Healthcare Acquisition's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition Earnings per Share (Diluted) Chart

Oracle Healthcare Acquisition Annual Data
Trend Dec05 Dec06 Dec07
Earnings per Share (Diluted)
- 0.36 0.33

Oracle Healthcare Acquisition Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
Earnings per Share (Diluted) Get a 7-Day Free Trial -0.02 0.10 0.10 -0.54 -0.38

Competitive Comparison of Oracle Healthcare Acquisition's Earnings per Share (Diluted)

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oracle Healthcare Acquisition's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's PE Ratio distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's PE Ratio falls into.



Oracle Healthcare Acquisition Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Oracle Healthcare Acquisition's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2007 is calculated as

Diluted Earnings Per Share (A: Dec. 2007 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(7.407-0)/22.259
=0.33

Oracle Healthcare Acquisition's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2007 is calculated as

Diluted Earnings Per Share (Q: Dec. 2007 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-7.172-0)/22.457
=-0.32

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Oracle Healthcare Acquisition  (OTCPK:OHAQ) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Oracle Healthcare Acquisition Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines